nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.202	0.274	CbGbCtD
Disopyramide—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.175	0.238	CbGbCtD
Disopyramide—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.162	0.22	CbGbCtD
Disopyramide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0555	0.0754	CbGbCtD
Disopyramide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0375	0.051	CbGbCtD
Disopyramide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0358	0.0486	CbGbCtD
Disopyramide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0319	0.0433	CbGbCtD
Disopyramide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0187	0.0254	CbGbCtD
Disopyramide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0177	0.024	CbGbCtD
Disopyramide—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.00247	0.857	CrCbGaD
Disopyramide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000881	0.0038	CcSEcCtD
Disopyramide—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000852	0.00367	CcSEcCtD
Disopyramide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000842	0.00363	CcSEcCtD
Disopyramide—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000826	0.00356	CcSEcCtD
Disopyramide—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000821	0.00354	CcSEcCtD
Disopyramide—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000817	0.00352	CcSEcCtD
Disopyramide—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000811	0.0035	CcSEcCtD
Disopyramide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000803	0.00346	CcSEcCtD
Disopyramide—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000794	0.00343	CcSEcCtD
Disopyramide—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000787	0.0034	CcSEcCtD
Disopyramide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000776	0.00335	CcSEcCtD
Disopyramide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00077	0.00332	CcSEcCtD
Disopyramide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00077	0.00332	CcSEcCtD
Disopyramide—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000753	0.00325	CcSEcCtD
Disopyramide—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000749	0.00323	CcSEcCtD
Disopyramide—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000749	0.00323	CcSEcCtD
Disopyramide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000746	0.00322	CcSEcCtD
Disopyramide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000746	0.00322	CcSEcCtD
Disopyramide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00074	0.00319	CcSEcCtD
Disopyramide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000739	0.00319	CcSEcCtD
Disopyramide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000738	0.00318	CcSEcCtD
Disopyramide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000735	0.00317	CcSEcCtD
Disopyramide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000731	0.00315	CcSEcCtD
Disopyramide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000726	0.00313	CcSEcCtD
Disopyramide—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000723	0.00312	CcSEcCtD
Disopyramide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000717	0.00309	CcSEcCtD
Disopyramide—Tension—Formoterol—chronic obstructive pulmonary disease	0.000716	0.00309	CcSEcCtD
Disopyramide—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000716	0.00309	CcSEcCtD
Disopyramide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000714	0.00308	CcSEcCtD
Disopyramide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000714	0.00308	CcSEcCtD
Disopyramide—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000708	0.00306	CcSEcCtD
Disopyramide—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000708	0.00306	CcSEcCtD
Disopyramide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000708	0.00305	CcSEcCtD
Disopyramide—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000707	0.00305	CcSEcCtD
Disopyramide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000697	0.00301	CcSEcCtD
Disopyramide—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000694	0.00299	CcSEcCtD
Disopyramide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000689	0.00297	CcSEcCtD
Disopyramide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00068	0.00293	CcSEcCtD
Disopyramide—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000679	0.00293	CcSEcCtD
Disopyramide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000677	0.00292	CcSEcCtD
Disopyramide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000677	0.00292	CcSEcCtD
Disopyramide—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000676	0.00292	CcSEcCtD
Disopyramide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00291	CcSEcCtD
Disopyramide—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000669	0.00289	CcSEcCtD
Disopyramide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000667	0.00288	CcSEcCtD
Disopyramide—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000667	0.00288	CcSEcCtD
Disopyramide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000667	0.00288	CcSEcCtD
Disopyramide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000662	0.00286	CcSEcCtD
Disopyramide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000658	0.00284	CcSEcCtD
Disopyramide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000658	0.00284	CcSEcCtD
Disopyramide—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000653	0.00282	CcSEcCtD
Disopyramide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000649	0.0028	CcSEcCtD
Disopyramide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000639	0.00276	CcSEcCtD
Disopyramide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000631	0.00272	CcSEcCtD
Disopyramide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000629	0.00271	CcSEcCtD
Disopyramide—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000624	0.00269	CcSEcCtD
Disopyramide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000621	0.00268	CcSEcCtD
Disopyramide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.00268	CcSEcCtD
Disopyramide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000621	0.00268	CcSEcCtD
Disopyramide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000621	0.00268	CcSEcCtD
Disopyramide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.00267	CcSEcCtD
Disopyramide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000618	0.00267	CcSEcCtD
Disopyramide—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000618	0.00266	CcSEcCtD
Disopyramide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.00265	CcSEcCtD
Disopyramide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000614	0.00265	CcSEcCtD
Disopyramide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000607	0.00262	CcSEcCtD
Disopyramide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000607	0.00262	CcSEcCtD
Disopyramide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000605	0.00261	CcSEcCtD
Disopyramide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000595	0.00257	CcSEcCtD
Disopyramide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000595	0.00257	CcSEcCtD
Disopyramide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000586	0.00253	CcSEcCtD
Disopyramide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000586	0.00253	CcSEcCtD
Disopyramide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000583	0.00252	CcSEcCtD
Disopyramide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000579	0.0025	CcSEcCtD
Disopyramide—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000579	0.0025	CcSEcCtD
Disopyramide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000578	0.00249	CcSEcCtD
Disopyramide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000578	0.00249	CcSEcCtD
Disopyramide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.00247	CcSEcCtD
Disopyramide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000571	0.00246	CcSEcCtD
Disopyramide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000571	0.00246	CcSEcCtD
Disopyramide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000566	0.00244	CcSEcCtD
Disopyramide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00242	CcSEcCtD
Disopyramide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.0024	CcSEcCtD
Disopyramide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000556	0.0024	CcSEcCtD
Disopyramide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000553	0.00239	CcSEcCtD
Disopyramide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000553	0.00239	CcSEcCtD
Disopyramide—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000552	0.00238	CcSEcCtD
Disopyramide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000546	0.00236	CcSEcCtD
Disopyramide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000543	0.00234	CcSEcCtD
Disopyramide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000538	0.00232	CcSEcCtD
Disopyramide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000538	0.00232	CcSEcCtD
Disopyramide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00231	CcSEcCtD
Disopyramide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000535	0.00231	CcSEcCtD
Disopyramide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000531	0.00229	CcSEcCtD
Disopyramide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000531	0.00229	CcSEcCtD
Disopyramide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000529	0.00228	CcSEcCtD
Disopyramide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000529	0.00228	CcSEcCtD
Disopyramide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000527	0.00227	CcSEcCtD
Disopyramide—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000526	0.00227	CcSEcCtD
Disopyramide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00227	CcSEcCtD
Disopyramide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00226	CcSEcCtD
Disopyramide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00226	CcSEcCtD
Disopyramide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00226	CcSEcCtD
Disopyramide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000522	0.00225	CcSEcCtD
Disopyramide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000518	0.00224	CcSEcCtD
Disopyramide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000517	0.00223	CcSEcCtD
Disopyramide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000516	0.00223	CcSEcCtD
Disopyramide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000513	0.00221	CcSEcCtD
Disopyramide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000513	0.00221	CcSEcCtD
Disopyramide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000513	0.00221	CcSEcCtD
Disopyramide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000509	0.0022	CcSEcCtD
Disopyramide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000509	0.0022	CcSEcCtD
Disopyramide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000509	0.0022	CcSEcCtD
Disopyramide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000509	0.0022	CcSEcCtD
Disopyramide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000508	0.00219	CcSEcCtD
Disopyramide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.00218	CcSEcCtD
Disopyramide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000503	0.00217	CcSEcCtD
Disopyramide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000501	0.00216	CcSEcCtD
Disopyramide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00216	CcSEcCtD
Disopyramide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000499	0.00215	CcSEcCtD
Disopyramide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000497	0.00215	CcSEcCtD
Disopyramide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00213	CcSEcCtD
Disopyramide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000493	0.00213	CcSEcCtD
Disopyramide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000493	0.00213	CcSEcCtD
Disopyramide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000491	0.00212	CcSEcCtD
Disopyramide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000491	0.00212	CcSEcCtD
Disopyramide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00049	0.00211	CcSEcCtD
Disopyramide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00211	CcSEcCtD
Disopyramide—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000488	0.00211	CcSEcCtD
Disopyramide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000488	0.0021	CcSEcCtD
Disopyramide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00209	CcSEcCtD
Disopyramide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00207	CcSEcCtD
Disopyramide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00207	CcSEcCtD
Disopyramide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00204	CcSEcCtD
Disopyramide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00204	CcSEcCtD
Disopyramide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000471	0.00203	CcSEcCtD
Disopyramide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000471	0.00203	CcSEcCtD
Disopyramide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000469	0.00202	CcSEcCtD
Disopyramide—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000466	0.00201	CcSEcCtD
Disopyramide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000465	0.00201	CcSEcCtD
Disopyramide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000465	0.002	CcSEcCtD
Disopyramide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000465	0.002	CcSEcCtD
Disopyramide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000463	0.002	CcSEcCtD
Disopyramide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000463	0.002	CcSEcCtD
Disopyramide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000462	0.00199	CcSEcCtD
Disopyramide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000462	0.00199	CcSEcCtD
Disopyramide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00199	CcSEcCtD
Disopyramide—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000453	0.00196	CcSEcCtD
Disopyramide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000447	0.00193	CcSEcCtD
Disopyramide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00192	CcSEcCtD
Disopyramide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000438	0.00189	CcSEcCtD
Disopyramide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000434	0.00187	CcSEcCtD
Disopyramide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000427	0.00184	CcSEcCtD
Disopyramide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.00184	CcSEcCtD
Disopyramide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00182	CcSEcCtD
Disopyramide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00182	CcSEcCtD
Disopyramide—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00042	0.00181	CcSEcCtD
Disopyramide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000418	0.0018	CcSEcCtD
Disopyramide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000415	0.00179	CcSEcCtD
Disopyramide—Methadone—CYP1A2—chronic obstructive pulmonary disease	0.000413	0.143	CrCbGaD
Disopyramide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000413	0.00178	CcSEcCtD
Disopyramide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.00176	CcSEcCtD
Disopyramide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000407	0.00176	CcSEcCtD
Disopyramide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000405	0.00175	CcSEcCtD
Disopyramide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00174	CcSEcCtD
Disopyramide—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000401	0.00173	CcSEcCtD
Disopyramide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00172	CcSEcCtD
Disopyramide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000398	0.00172	CcSEcCtD
Disopyramide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000394	0.0017	CcSEcCtD
Disopyramide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000394	0.0017	CcSEcCtD
Disopyramide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00166	CcSEcCtD
Disopyramide—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00166	CcSEcCtD
Disopyramide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00166	CcSEcCtD
Disopyramide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000379	0.00164	CcSEcCtD
Disopyramide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00163	CcSEcCtD
Disopyramide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00163	CcSEcCtD
Disopyramide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00162	CcSEcCtD
Disopyramide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00162	CcSEcCtD
Disopyramide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00162	CcSEcCtD
Disopyramide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00162	CcSEcCtD
Disopyramide—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000375	0.00162	CcSEcCtD
Disopyramide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00161	CcSEcCtD
Disopyramide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00161	CcSEcCtD
Disopyramide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000372	0.00161	CcSEcCtD
Disopyramide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000372	0.0016	CcSEcCtD
Disopyramide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000371	0.0016	CcSEcCtD
Disopyramide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000368	0.00159	CcSEcCtD
Disopyramide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000367	0.00158	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000367	0.00158	CcSEcCtD
Disopyramide—Depression—Prednisone—chronic obstructive pulmonary disease	0.000366	0.00158	CcSEcCtD
Disopyramide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00158	CcSEcCtD
Disopyramide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000361	0.00156	CcSEcCtD
Disopyramide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00154	CcSEcCtD
Disopyramide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000356	0.00154	CcSEcCtD
Disopyramide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.00153	CcSEcCtD
Disopyramide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00153	CcSEcCtD
Disopyramide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000354	0.00153	CcSEcCtD
Disopyramide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00153	CcSEcCtD
Disopyramide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00153	CcSEcCtD
Disopyramide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00153	CcSEcCtD
Disopyramide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00152	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.0015	CcSEcCtD
Disopyramide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000346	0.00149	CcSEcCtD
Disopyramide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000336	0.00145	CcSEcCtD
Disopyramide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00144	CcSEcCtD
Disopyramide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.00143	CcSEcCtD
Disopyramide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.00139	CcSEcCtD
Disopyramide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.00137	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000312	0.00134	CcSEcCtD
Disopyramide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000295	0.00127	CcSEcCtD
Disopyramide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.00126	CcSEcCtD
Disopyramide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.00125	CcSEcCtD
Disopyramide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00119	CcSEcCtD
Disopyramide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00117	CcSEcCtD
Disopyramide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000266	0.00115	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.00115	CcSEcCtD
Disopyramide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00113	CcSEcCtD
Disopyramide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00112	CcSEcCtD
Disopyramide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00111	CcSEcCtD
Disopyramide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00111	CcSEcCtD
Disopyramide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.0011	CcSEcCtD
Disopyramide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00109	CcSEcCtD
Disopyramide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00104	CcSEcCtD
Disopyramide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00101	CcSEcCtD
Disopyramide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000994	CcSEcCtD
Disopyramide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000982	CcSEcCtD
Disopyramide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000977	CcSEcCtD
Disopyramide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000963	CcSEcCtD
Disopyramide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00092	CcSEcCtD
Disopyramide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000914	CcSEcCtD
Disopyramide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000907	CcSEcCtD
Disopyramide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00089	CcSEcCtD
Disopyramide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000879	CcSEcCtD
Disopyramide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000877	CcSEcCtD
Disopyramide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000876	CcSEcCtD
Disopyramide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000871	CcSEcCtD
Disopyramide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000202	0.000871	CcSEcCtD
Disopyramide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000864	CcSEcCtD
Disopyramide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000833	CcSEcCtD
Disopyramide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000826	CcSEcCtD
Disopyramide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000803	CcSEcCtD
Disopyramide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000799	CcSEcCtD
Disopyramide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000725	CcSEcCtD
Disopyramide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000715	CcSEcCtD
Disopyramide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000691	CcSEcCtD
Disopyramide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000668	CcSEcCtD
Disopyramide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000643	CcSEcCtD
Disopyramide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000637	CcSEcCtD
Disopyramide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000637	CcSEcCtD
Disopyramide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000633	CcSEcCtD
Disopyramide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000139	0.0006	CcSEcCtD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.21e-05	0.00244	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	7.2e-05	0.00244	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.02e-05	0.00238	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	6.74e-05	0.00228	CbGpPWpGaD
Disopyramide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.55e-05	0.00222	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.5e-05	0.0022	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.48e-05	0.00219	CbGpPWpGaD
Disopyramide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.46e-05	0.00219	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	6.46e-05	0.00219	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	6.44e-05	0.00218	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.42e-05	0.00217	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	6.32e-05	0.00214	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	6.3e-05	0.00213	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	6.28e-05	0.00213	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	6.25e-05	0.00212	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	6.23e-05	0.00211	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	6.17e-05	0.00209	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.01e-05	0.00204	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APIP—chronic obstructive pulmonary disease	5.81e-05	0.00196	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	5.65e-05	0.00191	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	5.64e-05	0.00191	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	5.55e-05	0.00188	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.35e-05	0.00181	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.34e-05	0.00181	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.32e-05	0.0018	CbGpPWpGaD
Disopyramide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.31e-05	0.0018	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.31e-05	0.0018	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.29e-05	0.00179	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.26e-05	0.00178	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	5.17e-05	0.00175	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	5.17e-05	0.00175	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.89e-05	0.00165	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.87e-05	0.00165	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.85e-05	0.00164	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.82e-05	0.00163	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.79e-05	0.00162	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.77e-05	0.00161	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.72e-05	0.0016	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.67e-05	0.00158	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.62e-05	0.00156	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.56e-05	0.00154	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.54e-05	0.00154	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.5e-05	0.00152	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.47e-05	0.00151	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.46e-05	0.00151	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.35e-05	0.00147	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	4.35e-05	0.00147	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	4.34e-05	0.00147	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.27e-05	0.00145	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.19e-05	0.00142	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.17e-05	0.00141	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.16e-05	0.00141	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.14e-05	0.0014	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.13e-05	0.0014	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.13e-05	0.0014	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.09e-05	0.00139	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.09e-05	0.00138	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.08e-05	0.00138	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.06e-05	0.00138	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	4.05e-05	0.00137	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.04e-05	0.00137	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.03e-05	0.00136	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.91e-05	0.00132	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.88e-05	0.00131	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.85e-05	0.0013	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.83e-05	0.0013	CbGpPWpGaD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.82e-05	0.00129	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.76e-05	0.00127	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	3.74e-05	0.00127	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.67e-05	0.00124	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.66e-05	0.00124	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.64e-05	0.00123	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.63e-05	0.00123	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.63e-05	0.00123	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.62e-05	0.00122	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.6e-05	0.00122	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.52e-05	0.00119	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.48e-05	0.00118	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.46e-05	0.00117	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.42e-05	0.00116	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.41e-05	0.00115	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	3.38e-05	0.00114	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.34e-05	0.00113	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.33e-05	0.00113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.29e-05	0.00111	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.24e-05	0.0011	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.23e-05	0.00109	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.23e-05	0.00109	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.22e-05	0.00109	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.21e-05	0.00109	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.19e-05	0.00108	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.19e-05	0.00108	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.18e-05	0.00108	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.18e-05	0.00108	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.15e-05	0.00107	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.11e-05	0.00105	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.1e-05	0.00105	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.98e-05	0.00101	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.93e-05	0.000993	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.82e-05	0.000955	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.79e-05	0.000944	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.78e-05	0.000942	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.7e-05	0.000915	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.59e-05	0.000875	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.58e-05	0.000873	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.56e-05	0.000867	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.55e-05	0.000864	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.55e-05	0.000864	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	2.54e-05	0.000861	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.51e-05	0.00085	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.5e-05	0.000847	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.44e-05	0.000827	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.44e-05	0.000825	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.41e-05	0.000817	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.39e-05	0.000809	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.37e-05	0.000803	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.35e-05	0.000794	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.3e-05	0.00078	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.3e-05	0.000777	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.27e-05	0.00077	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.27e-05	0.000768	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.26e-05	0.000766	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.21e-05	0.000749	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.19e-05	0.00074	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.14e-05	0.000725	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.09e-05	0.000708	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.09e-05	0.000706	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.08e-05	0.000704	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.07e-05	0.000701	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.07e-05	0.000699	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.06e-05	0.000697	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.05e-05	0.000695	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.04e-05	0.000692	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.03e-05	0.000688	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.02e-05	0.000684	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2e-05	0.000675	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000668	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.97e-05	0.000667	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.97e-05	0.000667	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.96e-05	0.000665	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.96e-05	0.000664	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.96e-05	0.000664	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.96e-05	0.000662	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.95e-05	0.000658	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.94e-05	0.000658	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.94e-05	0.000656	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.93e-05	0.000653	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.87e-05	0.000633	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.86e-05	0.000631	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.85e-05	0.000625	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.84e-05	0.000624	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.84e-05	0.000622	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.8e-05	0.00061	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.8e-05	0.000608	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.78e-05	0.000602	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.7e-05	0.000575	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.65e-05	0.000557	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.64e-05	0.000554	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.63e-05	0.000552	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.62e-05	0.000549	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.61e-05	0.000547	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.53e-05	0.000519	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.51e-05	0.000512	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.51e-05	0.000512	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.5e-05	0.000509	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.46e-05	0.000495	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.44e-05	0.000488	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.44e-05	0.000486	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000485	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.42e-05	0.000481	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.42e-05	0.000479	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.41e-05	0.000477	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.4e-05	0.000473	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.36e-05	0.00046	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.34e-05	0.000453	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	0.000452	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.34e-05	0.000452	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.32e-05	0.000448	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.3e-05	0.000441	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.24e-05	0.000418	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.000418	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.23e-05	0.000417	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.22e-05	0.000413	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.11e-05	0.000377	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.11e-05	0.000375	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.1e-05	0.000374	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.1e-05	0.000373	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.1e-05	0.000372	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.09e-05	0.000369	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.01e-05	0.000342	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.01e-05	0.000341	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1e-05	0.00034	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1e-05	0.000339	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.98e-06	0.000338	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.91e-06	0.000335	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	9.74e-06	0.00033	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.66e-06	0.000327	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.63e-06	0.000326	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.54e-06	0.000323	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.32e-06	0.000315	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	9.08e-06	0.000307	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.98e-06	0.000304	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.96e-06	0.000303	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.87e-06	0.0003	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.69e-06	0.000294	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	8.39e-06	0.000284	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	8.02e-06	0.000272	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.99e-06	0.00027	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.9e-06	0.000267	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.39e-06	0.00025	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.36e-06	0.000249	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.29e-06	0.000247	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.21e-06	0.000244	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.05e-06	0.000239	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.03e-06	0.000238	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.96e-06	0.000236	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.73e-06	0.000228	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.71e-06	0.000227	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.64e-06	0.000225	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.64e-06	0.000225	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.97e-06	0.000202	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.95e-06	0.000201	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.89e-06	0.000199	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.68e-06	0.000192	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.66e-06	0.000192	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.6e-06	0.00019	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.54e-06	0.000187	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.46e-06	0.000185	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.4e-06	0.000183	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.38e-06	0.000182	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.33e-06	0.00018	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.09e-06	0.000172	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.85e-06	0.000164	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.83e-06	0.000164	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.82e-06	0.000163	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.79e-06	0.000162	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.45e-06	0.000151	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.44e-06	0.00015	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.39e-06	0.000149	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.36e-06	0.000148	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.35e-06	0.000147	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.31e-06	0.000146	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.66e-06	0.000124	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.65e-06	0.000124	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.62e-06	0.000122	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.35e-06	0.000114	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.34e-06	0.000113	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.31e-06	0.000112	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.28e-06	0.000111	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.14e-06	0.000106	CbGpPWpGaD
